About Index Trending news
Analyze
Top 50 Pricing
InVivo Therapeutics

InVivo Therapeutics

Work at InVivo Therapeutics? Add yourself to this profile

InVivo Therapeutics

InVivo Therapeutics (NASDAQ:NVIV) is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO equity
$32,200,000
Venture capital
$13,000,000
Employees

Team size

10+
Locations
HQ
$32,200,000 Post-IPO equity
MassDevice

InVivo raises $32m, enrolls 7th patient in Inspire study